Obama to tout progress on Ebola vaccine at NIH

President ObamaBarack Hussein ObamaThe bully who pulls the levers of Trump's mind never learns US-China space cooperation is up in the air more than ever GOP infighting takes stupid to a whole new level MORE will speak at the National Institutes of Health (NIH) on Tuesday to tout progress on a much-needed Ebola vaccine that has shown promise in early trials.

Obama will travel to Bethesda, Md., to applaud the work of NIH Director Dr. Francis Collins and National Institute of Allergy and Infectious Diseases Director Dr. Anthony FauciAnthony FauciStudy: Omicron could be more transmissible due to sharing genetic material with common cold Sunday shows preview: Multiple states detect cases of the omicron variant Three omicron cases of COVID-19 identified in Maryland: Gov. Hogan MORE, as well as “discuss progress on other fronts on the fight against Ebola,” according to the White House.

Obama will also use the address to “make the case” for his $6.2 billion funding request for the fight against Ebola.

The remarks, which will be his first on Ebola in more than a month, come as lawmakers continue to hammer out details on an appropriations bill before Dec. 12.

Trials on the potential vaccine, which was co-developed by pharmaceutical giant GlaxoSmithKline, began in early September.

One of the top United Nations doctors leading the Ebola response, though, warned Monday that while early data on the vaccine candidate has been promising, it will not solve the current international crisis.

“The vaccines are really, really important, but we still have to do everything else,” Dr. Bruce Aylward, who leads the World Health Organization’s on-the-ground response to Ebola, told reporters. “There’s a big risk that people think it's going to solve the problem. It’s not.”

More than 17,000 cases of Ebola have been reported globally, nearly all in Sierra Leone, Liberia and Guinea.